Cabergoline Administration after Ovariohysterectomy in a Queen with Fibroepithelial Hyperplasia

Abstract

In this case report, the diagnosis and treatment process of fibroepithelial hyperplasia developing in the mammary glands of an 11-month-old Tabby queen is presented. Anamnesis that the queen had been in estrus once before, it mammaries were gradually swollen in the last 15 days, her appetite and general condition were normal, and there was no previous progesterone administration. On physical examination, all mammary lobes were excessively tight bilaterally, swollen mammaries were gel-like and painless on palpation, hyperemia and milk secretion around the nipples were noted. Laboratory tests showed that serum progesterone level was 3.02 ng/mL and estrogen level was 5.2 pg/mL. Fibroepithelial hyperplasia was diagnosed based on anamnesis, clinical examination, and laboratory analysis. Ovariohysterectomy operation was performed as the treatment. One day after the operation, cabergoline was administered orally at a dose of 5 µg/kg/day for 5 days. At the two weeks-follow-up examination, a significant regression in the mammary glands size and a end of milk production were observed. In conclusion, fibroepithelial hyperplasia in the mammary glands of a young queen that was brought to our clinic were successfully cured endogenously by surgical method and exogenously by medical drug administration.